Page last updated: 2024-08-18

isomethyleugenol and Peanut Hypersensitivity

isomethyleugenol has been researched along with Peanut Hypersensitivity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berglund, JP; Bucayu, R; Galli, SJ; Garcia, MA; Ishida, S; Kohli, A; Lyu, SC; Maecker, H; Nadeau, KC; O'Riordan, G; Syed, A; Tsai, M1
Pearson, H1

Trials

1 trial(s) available for isomethyleugenol and Peanut Hypersensitivity

ArticleYear
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
    The Journal of allergy and clinical immunology, 2014, Volume: 133, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Antigens; Arachis; Child; Child, Preschool; Dendritic Cells; Desensitization, Immunologic; Double-Blind Method; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunoglobulin E; Immunoglobulin G; Male; Methylation; Middle Aged; Peanut Hypersensitivity; T-Lymphocytes, Regulatory; Young Adult

2014

Other Studies

1 other study(ies) available for isomethyleugenol and Peanut Hypersensitivity

ArticleYear
Children of the 90s: Coming of age.
    Nature, 2012, Apr-11, Volume: 484, Issue:7393

    Topics: Adolescent; Age Distribution; Biological Specimen Banks; Child; Family Characteristics; Female; Genome, Human; Health Surveys; Heredity; History, 20th Century; History, 21st Century; Humans; Infant; Longitudinal Studies; Methylation; Obesity; Peanut Hypersensitivity; Pregnancy; Surveys and Questionnaires; United Kingdom; Young Adult

2012